Background -Improvement of allergic
Background -Improvement of allergic asthma is seen at high altitude partly because of low concentrations of allergen, especially house dust mite. To investigate the effect of a hypoallergenic environment (Davos, 1560 m) on airways inflammation, the changes in bronchial hyperresponsiveness measured with methacholine and adenosine 5'-monophosphate (AMP), blood eosinophils, eosinophil cationic protein (ECP), and serum IgE were studied. Methods -In 16 allergic asthmatic children tests were performed on admission and after one month. Medication was kept unchanged during the month ofinvestigation and the patients performed peak expiratory flow (PEF) measurements twice daily. Results -After one month at high altitude a considerable improvement was seen in the provocative concentration of AMP causing a 20% fall in forced expiratory volume in one second (PC20 AMP), but not with methacholine. There was also a reduction in total blood eosinophils and ECP. No change in serum IgE was observed. Peak flow variability decreased. Conclusions -After one month at high altitude a reduction in airways inflammation occurs. The results indicate that AMP responsiveness is a more accurate marker of disease activity in relation to inflammation in asthma than methacholine. The aim of our study was to investigate the effect of a hypoallergenic environment on airway inflammation measured by direct and indirect bronchial hyperresponsiveness, blood eosinophil counts, serum levels of eosinophil cationic protein (ECP), and total IgE in relation to peak expiratory flow rate (PEF) and forced expiratory volume in one second (FEV,) in children with allergic asthma. In order to obtain reliable results, the medical treatment on admission was continued and kept unchanged during the month of investigation.
Methods
Sixteen children with allergic asthma as defined by the ATS6 participated in the study. All came from The Netherlands and were admitted to the Dutch Asthmacentre between September 1993 and March 1994. Their characteristics are summarised in table 1. At the time of admission they had been receiving regular antiinflammatory and bronchodilator drugs for many years and their medication was continued in the same doses as in The Netherlands. Exacerbations and viral infections did not occur during the first month so no adjustment of medication was necessary.
The morning after arrival blood samples were taken and lung function was measured. Methacholine challenge was performed on the second day after arrival and AMP provocation tests were done 72 hours later. After one month all the tests were performed again at the same time of the day and in the same order. During the month of the study the children performed PEF twice daily using a mini-Wright peak flow meter and the best of three PEF manoeuvres was recorded. The variation in PEF was defined as the highest-the lowest value in a 24 hour period/the mean 24 hour value. The mean values of the first and the fifth week were used for the peak flow recordings.
The levels of bronchial hyperresponsiveness were evaluated by methacholine bromide and Effect of allergen avoidance at high altitude on children with allergic asthma The geometric mean (SE) number of eosinophils decreased from 372-39 (87 04)/mm3 to 233-35 (67-83)/mm3 (p<0-01; 95% CI 0-060 to 0-346). Serum ECP levels also showed a reduction from 15-24 (5A42) jig/Ito 8&97 (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (p<005), but no change was seen in total IgE levels (from 961-61 (512-82 kU/l to 957-19 (475 66) kU/1).
No correlation could be observed between the changes in bronchial hyperresponsiveness measured with AMP and methacholine and the changes in eosinophils, ECP, serum IgE, and peak flow variability.
Discussion
In this group of children we were able to show that, after one month in an environment free from the house dust mite, an improvement in bronchial hyperresponsiveness measured with AMP but not with methacholine is found. In addition, a reduction in total eosinophils and ECP was observed during this period, together with a beneficial effect in PEF variability. Our findings concerning ECP and eosinophils are supported by those of Boner et a14 who also observed a reduction in serum IgE after three months of allergen avoidance. Although serum IgE has a relatively short half life, we did not observe any change in IgE levels after one month. One possible explanation for this is that the children had undergone a high level of exposure to the allergen before the start of the study which caused a latent increase in IgE levels during the early part of the investigation, since all children were admitted in the winter season. Boner et al did not observe a relationship between bronchial hyperresponsiveness and any of the blood measurements at high altitude4 and nor did we. That no correlation between the change in PEF variability and ECP was seen in our study can be explained by the fact that the ECP levels were within the normal range, probably caused by the steroid medication.'
Convincing evidence of an association between allergen load and bronchial hyperresponsiveness in asthma is shown by the worsening bronchial hyperresponsiveness after allergen challenge3 and the improvement, especially in indirect bronchial hyperresponsiveness as shown in this study, when a patient is moved to an allergen free environment. The large change in AMP responsiveness but not in methacholine responsiveness is intriguing in this respect and indicates the heterogeneity of bronchial provocation tests as shown in previous studies.3910 The large reduction in AMP responsiveness may indicate a reduction in mast cell numbers or a reduction in mast cell responsiveness to AMP, or a reduction in the target tissue response to the mediators as a result of allergen avoidance. The latter seems unlikely because of the relative stability of the methacholine response. It is known that corticosteroids reduce responsiveness to AMP more than to other stimuli. This AMP responsiveness seems to be a sensitive marker for the underlying inflammation in asthma. Allergen avoidance may have the same or even a better and more rapid effect on AMP responsiveness, as demonstrated in this study. One could argue that the medication taken during the study may have influenced the results. However, since all medication was kept unchanged, it suggests that the changes observed were a consequence of allergen avoidance.
The results of this study confirm that a stay at high altitude reduces airway inflammation in patients with asthma and indicate that AMP is a more accurate marker of disease activity in relation to inflammation than methacholine. Allergen avoidance at high altitude has important clinical implications for children with allergic asthma. 
